Reuters
@Reuters·4.2M subscribers·86.9K videos
How the GLP-1 threat became an opportunity for Nestle
Posted
August 17, 2026
Views
784
Likes
25
Comments
4
Engagement
3.70%
August 17, 2026
784
25
4
3.70%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:27Now PlayingNestle shifts strategy on GLP-1 weight-loss drugs, developing protein, collagen and nutrient products to address side effects for users.
#News #Reuters #Newsfeed #nestle #business #restructuring #nutrients
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on X
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
